Advanced search
Publication Cover
Pain Management Volume 1, 2011 - Issue 4
Submit an article Journal homepage
138
Views
0
CrossRef citations to date
0
Altmetric
Review

Diagnosis and Management of Trigeminal Neuropathic Pains

Joel J Napeñas1 Department of Oral Medicine, Carolinas Medical Center, Charlotte, NC, USA. Correspondence[email protected]
View further author information
&
Joanna M Zakrzewska2 Division of Diagnostic, Surgical and Medical Sciences, Eastman Dental Hospital, London, UKView further author information
Pages 353-365 | Published online: 04 Jul 2011

Bibliography

  • Treede RD , JensenTS, CampbellJN et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70(18) , 1630–1635 (2008).
  • Fried K , BongenhielmU, BoissonadeFM, RobinsonPP. Nerve injury-induced pain in the trigeminal system. Neuroscientist7(2) , 155–165 (2001).
  • Finnerup NB , SindrupSH, JensenTS. Chronic neuropathic pain: mechanisms, drug targets and measurement. Fundam. Clin. Pharmacol.21(2) , 129–136 (2007).
  • Clark JD . Chronic pain prevalence and analgesic prescribing in a general medical population. J. Pain Symptom Manage.23(2) , 131–137 (2002).
  • Hasselstrom J , Liu-PalmgrenJ, Rasjo-WraakG. Prevalence of pain in general practice. Eur. J. Pain6(5) , 375–385 (2002).
  • Koleva D , KrulichovaI, BertoliniG, CaimiV, GarattiniL. Pain in primary care: an Italian survey. Eur. J. Public Health15(5) , 475–479 (2005).
  • McDermott AM , ToelleTR, RowbothamDJ, SchaeferCP, DukesEM. The burden of neuropathic pain: results from a cross-sectional survey. Eur. J. Pain10(2) , 127–135 (2006).
  • Meyer-Rosberg K , KvarnstromA, KinnmanE, GordhT, NordforsLO, KristoffersonA. Peripheral neuropathic pain – a multidimensional burden for patients. Eur. J. Pain5(4) , 379–389 (2001).
  • Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders (2nd Edition). Cephalalgia24(Suppl. 1) , 9–160 (2004).
  • Olesen J . The future of headache classification and classification research. Cephalalgia29(12) , 1240–1241 (2009).
  • Olesen J . New plans for headache classification: ICHD-3. Cephalalgia31(1) , 4–5 (2011).
  • Orofacial Pain and Headache. Sharav Y, Benoliel R (Ed.). Elsevier, London, UK (2008).
  • Nixdorf DR , DrangsholtM, EttlinDA et al. Classifying orofacial pains: developing a taxonomy using ontological principles. J. Oral Rehab. (2011) (In Press).
  • Treede RD , JensenTS, CampbellJN et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology 70(18) , 1630–1635 (2008).
  • Forssell H , JaaskelainenS, TenovuoO, HinkkaS. Sensory dysfunction in burning mouth syndrome. Pain99(1–2) , 41–47 (2002).
  • Cohen AS , MatharuMS, GoadsbyPJ. Trigeminal autonomic cephalalgias: current and future treatments. Headache47(6) , 969–980 (2007).
  • Olesen J , Bousser M-G, Diener HC et al. The International Classification of Headache Disorders (2nd Edition). Cephalgia24(Suppl. 1) , 24–150 (2004).
  • Zakrzewska JM , HamlynPJ: Facial pain. In: Epidemiology of Pain: A Report of the Task Force on Epidemiology (1st Edition). Crombie IKCPR, Linton SJ, LeResche L, Von Korff M (Eds). IASP Press, Seattle, USA, 171–202 (1999).
  • Koopman JS , DielemanJP, HuygenFJ, de Mos M, Martin CG, Sturkenboom MC. Incidence of facial pain in the general population. Pain147(1–3) , 122–127 (2009).
  • Hall GC , CarrollD, ParryD, McQuayHJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain122(1–2) , 156–162 (2006).
  • Peker S , DincerA, Necmettin Pamir M. Vascular compression of the trigeminal nerve is a frequent finding in asymptomatic individuals: 3-T MR imaging of 200 trigeminal nerves using 3D CISS sequences. Acta Neurochir. (Wien)151(9) , 1081–1088 (2009).
  • Ishikawa M , NishiS, AokiT et al. Operative findings in cases of trigeminal neuralgia without vascular compression: proposal of a different mechanism. J. Clin. Neurosci. 9(2) , 200–204 (2002).
  • Devor M , AmirR, RappaportZH. Pathophysiology of trigeminal neuralgia: the ignition hypothesis. Clin. J. Pain18(1) , 4–13 (2002).
  • Fromm GH , TerrenceCF, MaroonJC. Trigeminal neuralgia. Current concepts regarding etiology and pathogenesis. Arch. Neurol.41(11) , 1204–1207 (1984).
  • Dubner R , SharavY, GracelyRH, PrinceDD. Idiopathic trigeminal neuralgia: sensory features and pain mechanisms. Pain31(1) , 23–33 (1987).
  • Moisset X , VillainN, DucreuxD et al. Functional brain imaging of trigeminal neuralgia. Eur. J. Pain 15(2) , 124–131 (2011).
  • King RB . Evidence for a central etiology of tic douloureux. J. Neurosurg.26(1) , 175–180 (1967).
  • Greenwood LF , SessleBJ. Inputs to trigeminal brain stem neurons from facial, oral, tooth, pulp and pharyngolaryngeal tissues: II. Role of trigeminal nucleus caudalis in modulating responses to innocuous and noxious stimuli. Brain Res.117(2) , 227–238 (1976).
  • Obermann M , YoonMS, EseD et al. Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology 69(9) , 835–841 (2007).
  • Bowsher D . Trigeminal neuralgia: a symptomatic study of 126 successive patients with and without previous interventions. Pain Clinic12(2) , 93–98 (2000).
  • Limonadi FM , McCartneyS, BurchielKJ. Design of an artificial neural network for diagnosis of facial pain syndromes. Stereotact. Funct. Neurosurg.84(5–6) , 212–220 (2006).
  • Zakrezewska JM , LinskeyME. Trigeminal neuralgia. In: Orofacial Pain (1st Edition). Zakrzewska JM (Ed.). Oxford University Press, Oxford, UK, 83–92 (2009).
  • Tolle T , DukesE, SadoskyA. Patient burden of trigeminal neuralgia: results from a cross-sectional survey of health state impairment and treatment patterns in xix European countries. Pain Pract.6(3) , 153–160 (2006).
  • Zakrzewska JM , SawsanJ, BulmanJS. A prospective, longitudinal study on patients with trigeminal neuralgia who underwent radiofrequency thermocoagulation of the Gasserian ganglion. Pain79(1) , 51–58 (1999).
  • Insights: Facts and Stories Behind Trigeminal Neuralgia. Zakrzewska JM (Ed.). Trigeminal Neuralgia Association, Gainesville, FL, USA, 1–403 (2006).
  • Rozen TD . Trigeminal neuralgia and glossopharyngeal neuralgia. Neurol. Clin. N. Am.22(1) , 185–206 (2004).
  • Zakrzewska JM , PatsalosPN. Long-term cohort study comparing medical (oxcarbazepine) and surgical management of intractable trigeminal neuralgia. Pain95(3) , 259–266 (2002).
  • Wiffen PJ , DerryS, MooreRA, McQuayHJ. Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst. Rev.1 , CD005451 (2011).
  • Miller AD , KraussGL, HamzehFM. Improved CNS tolerability following conversion from immediate-to extend-release carbamazepine. Acta Neurol. Scand.109(6) , 374–377 (2004).
  • Beydoun A , SchmidtD, D‘SouzaJ. Oxcarbazepine versus carbamazepine in trigeminal neuralgia: a meta-analysis of three double blind comparative trials. Neurology3(Suppl.) , 2 (2002).
  • Canavero S , BonicalziV, FerroliP, ZerneS, MontalentiE, BennaP. Lamotrigine control of idiopathic trigeminal neuralgia [letter]. J. Neurol. Neurosurg. Psychiatry59(6) , 646 (1995).
  • Lunardi G , LeandriM, AlbanoC et al. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology 48(6) , 1714–1717 (1997).
  • Zakrzewska JM , ChaudhryZ, NurmikkoTJ, PattonDW, MullensEL. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain73(2) , 223–230 (1997).
  • Yang M , ZhouM, HeL et al. Non-antiepileptic drugs for trigeminal neuralgia. Cochrane Database Syst. Rev. 1 , CD004029 (2011).
  • Cruccu G , GronsethG, AlksneJ et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur. J. Neurol. 15(10) , 1013–1028 (2008).
  • Gronseth G , CruccuG, AlksneJ et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 71(15) , 1183–1190 (2008).
  • Zakrzewska JM , LopezBC. Quality of reporting in evaluations of surgical treatment of trigeminal neuralgia: recommendations for future reports. Neurosurgery53(1) , 110–120 (2003).
  • Zakrzewska JM . Surgery for trigeminal neuralgia? Pain152(3) , 469–470 (2011).
  • Kano H , KondziolkaD, YangHC et al. Outcome predictors after gamma knife radiosurgery for recurrent trigeminal neuralgia. Neurosurgery 67(6) , 1637–1644 (2010).
  • Zakrzewska JM , JornsTP, SpatzA. Patient led conferences – who attends, are their expectations met and do they vary in three different countries? Eur. J. Pain13(5) , 486–491 (2009).
  • Berge TI . Incidence of chronic neuropathic pain subsequent to surgical removal of impacted third molars. Acta Odontol. Scand.60(2) , 108–112 (2002).
  • Polycarpou N , NgYL, CanavanD, MolesDR, GulabivalaK. Prevalence of persistent pain after endodontic treatment and factors affecting its occurrence in cases with complete radiographic healing. Int. Endod. J.38(3) , 169–178 (2005).
  • Baad-Hansen L . Atypical odontalgia – pathophysiology and clinical management. J. Oral Rehabil.35(1) , 1–11 (2008).
  • List T , LeijonG, HelkimoM, OsterA, DworkinSF, SvenssonP. Clinical findings and psychosocial factors in patients with atypical odontalgia: a case–control study. J. Orofac. Pain21(2) , 89–98 (2007).
  • Forssell H , TenovuoO, SilvoniemiP, JaasklainenSK. Differences and similarities between atypical facial pain and trigeminal neuropathic pain. Neurology69(14) , 1451–1459 (2007).
  • Baad-Hansen L , ListT, KaubeH, JensenTS, SvenssonP. Blink reflexes in patients with atypical odontalgia and matched healthy controls. Exp. Brain Res.172(4) , 498–506 (2006).
  • Julius D , BasbaumAI. Molecular mechanisms of nociception. Nature413(6852) , 203–210 (2001).
  • Devor M , SeltzerZ. Pathophysiology of damaged nerves in relation to chronic pain. In: Pain. Wall PD, Melzack R (Eds). Churchill Livingstone, London, UK (1999)
  • Eliav E , BenolielR, TalM. Inflammation with no axonal damage of the rat saphenous nerve trunk induces ectopic discharge and mechanosensitivity in myelinated axons. Neurosci. Lett.311(1) , 49–52 (2001).
  • Woolf CJ , SalterMW. Neuronal plasticity: increasing the gain in pain. Science288(5472) , 1765–1769 (2000).
  • Moore KA , HohnoT, KarchewskiLA, ScholzJ, BabaH, WoolfCJ. Partial peripheral nerve injury promotes a selective loss of GABAergic inhibition in the superficial dorsal horn of the spinal cord. J. Neurosci.22(15) , 6724–6731 (2002).
  • Porreca F , OssipovMH, GebhartGF. Chronic pain and medullary descending facilitation. Trends Neurosci.25(6) , 319–325 (2002).
  • List T , LeijonG, HelkimoM, OsterA, SvenssonP. Effect of local anesthesia on atypical odontalgia – a randomized controlled trial. Pain122(3) , 306–314 (2006).
  • Baad-Hansen L , JuhlGI, JensenTS, BrandsborgB, SvenssonP. Differential effect of intravenous S-ketamine and fentanyl on atypical odontalgia and capsaicin-evoked pain. Pain129(1–2) , 46–54 (2007).
  • Landefeld CS , SteinmanMA. The Neurontin legacy – marketing through misinformation and manipulation. N. Engl. J. Med.360(2) , 103–106 (2009).
  • Vedula SS , BeroL, SchererRW, DickersinK. Outcome reporting in industry-sponsored trials of gabapenitn for off-label use. N. Engl. J. Med.361(20) , 1963–1971 (2009).
  • O‘Connor AB , DworkinRH. Treatment of neuropathic pain: an overview of recent guidelines. Am. J. Med.122(Suppl. 10) , S22–S32 (2009).
  • Otto M , BachFW, JensenTS, BrosenK, SindrupSH. Escitalopram in painful polyneuropathy: a randomized, placebo-controlled cross-over trial. Pain139(2) , 275–283 (2008).
  • Gerber PE , LyndLD. Selective serotonin-reuptake inhibitor-induced movement disorders. Ann. Pharmacother.32(6) , 692–698 (1998).
  • Lynch ME , ClarkAJ, SawynokJ, SullivanMJ. Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. J. Pain6(10) , 644–649 (2005).
  • Canavan D , Graff-RadfordSB, GrattBM. Traumatic dysesthesia of the trigeminal nerve. J. Orofac. Pain8(4) , 391–396 (1994).
  • Davies PS , GalerBS. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs64(9) , 937–947 (2004).
  • Campero M , BostockH, BaumannTK, OchoaJL. A search for activation of C nociceptors by sympathetic fibers in complex regional pain syndrome. Clin. Neurophysiol.121(7) , 1072–1079 (2010).
  • O‘Connell NE , WandBM, MarstonL, SpencerS, DesouzaLH. Non-invasive brain stimulation techniques for chronic pain. Cochrane Database Syst. Rev.8(9) , CD008208 (2010).
  • Tammiala-Salonen T , HiidenkariT, ParvinenT. Burning mouth in a Finnish adult population. Community Dent. Oral Epidemiol.21(2) , 67–71 (1993).
  • Woda A , GrushkaM. Burning mouth syndrome. In: Orofacial Pain (1st Edition). Zakrzewska JM (Ed.). Oxford University Press, Oxford, UK, 83–92 (2009).
  • Eliav E , KamranB, SchahamR, CzerninskiR, GracelyRH, BenolielR. Evidence of chorda tympani dysfunction in patients with burning mouth syndrome. J. Am. Dent. Assoc.138(5) , 628–633 (2007).
  • Woda A , DaoT, Gremeau-RichardC. Steroid dysregulation and stomatodynia (burning mouth syndrome). J. Orofac. Pain23(3) , 202–210 (2009).
  • Bergdahl M , BergdahlJ. Burning mouth syndrome: prevalence and associated factors. J. Oral Pathol. Med.28(8) , 350–354 (1999).
  • Sardella A , LodiG, DemarosiF, BezC, CassanoS, CarrassiA. Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments. Oral Dis.12(2) , 152–155 (2006).
  • Buchanan J , ZakrzewskaJ. Burning mouth syndrome. Clin. Evid. (Online)14 , 1301 (2008).
  • Zakrzewska JM , ForssellH, GlennyAM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst. Rev.1 , CD002779 (2005).
  • Bergdahl J , AnnerothG, PerrisH. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: a controlled study. J. Oral Pathol. Med.24(5) , 213–215 (1995).
  • Fromm GH , TerrenceCF. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology37(11) , 1725–1728 (1987).
  • Parekh S , ShahK, KotdadawallaH, GandhiI. Baclofen in carbamazepine resistant trigeminal neuralgia: double-blind study and long-term follow up. Ann. Neurol.9 , 392–393 (1989).
  • Campbell FG , GrahamJG, ZilkhaKJ. Clinical trial of carbamazepine (tegretol) in trigeminal neuralgia. J. Neurol. Neurosurg. Psychiatry29(3) , 265–267 (1966).
  • Killian JM , FrommGH. Carbamazepine in the treatment of neuralgia. Arch. Neurol.19(2) , 129–136 (1968).
  • Nicol CF . A four year double-blind study of tegretol in facial pain. Headache9(1) , 54–57 (1969).
  • Lemos L , FloresS, OliveiraP, AlmeidaA. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin. J. Pain24(1) , 64–75 (2008).
  • Liebel JT , MengerN, LangohrH. Oxcarbazepine in der behandlung der trigeminusneuralgie. Nervenheilkunde20 , 461–465 (2001).
  • Beydoun A , KutluayE. Oxcarbazepine. Expert Opin. Pharmacother.3(1) , 59–71 (2002).
  • Caccia MR . Clonazepam in facial neuralgia and cluster headache. Clinical and electrophysiological study. Eur. Neurol.13(6) , 560–563 (1975).
  • Chandra B . The use of clonazepam in the treatment of tic douloureux (a preliminary report). Proc. Aust. Assoc. Neurol.13 , 119–122 (1976).
  • Court JE , KaseCS. Treatment of tic douloureux with a new anticonvulsant (clonazepam). J. Neurol. Neurosurg. Psychiatry39(3) , 297–299 (1976).
  • Smirne S , ScarlatoG. Clonazepam in cranial neuralgias. Med. J. Aust.1(4) , 93–94 (1977).
  • Iannone A , BakerAB, MorrellF. Dilantin in the treatment of trigeminal neuralgia. Neurology8(2) , 126–128 (1958).
  • Braham J , SaiaA. Phenytoin in the treatment of trigeminal and other neuralgias. Lancet2 , 892–893 (1960).
  • Chinitz A , SeelingerDF, GreenhouseAH. Anticonvulsant therapy in trigeminal neuralgia. Am. J. Med. Sci.252(1) , 62–67 (1966).
  • Obermann M , YoonMS, SensenK, MaschkeM, DienerHC, KatsaravaZ. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalgia28(2) , 174–181 (2008).
  • Perez C , NavarroA, SaldanaMT, MartinezS, RejasJ. Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: evidence from medical practice in primary care settings. Cephalgia29(7) , 781–790 (2009).
  • Eide PK , RabbenT, SkjelbredP, StubhaugA. The effect of peripheral glycerol on trigeminal neuropathic pain examined by quantitative assessment of abnormal pain and sensory perception. Acta Neurochir. (Wien)140(12) , 1271–1277 (1998).
  • Fardy MJ , ZakrzewskaJM, PattonDW. Peripheral surgical techniques for the management of trigeminal neuralgia – alcohol and glycerol injections. Acta Neurochir. (Wien)129(3–4) , 181–184 (1994).
  • Erdem E , AlkanA. Peripheral glycerol injections in the treatment of idiopathic trigeminal neuralgia: retrospective analysis of 157 cases. J. Oral Maxillofac. Surg.59(10) , 1176–1180 (2001).
  • Pradel W , HlawitschkaM, EckeltU, HerzogR, KochK. Cryosurgical treatment of genuine trigeminal neuralgia. Br. J. Oral Maxillofac. Surg.40(3) , 244–247 (2002).
  • Zakrzewska JM . Cryotherapy for trigeminal neuralgia: a 10 year audit. Br. J. Oral Maxillofac. Surg.29(1) , 1–4 (1991).
  • Pollock BE . Percutaneous retrogasserian glycerol rhizotomy for patients with idiopathic trigeminal neuralgia: a prospective analysis of factors related to pain relief. J. Neurosurg.102(2) , 223–228 (2005).
  • Lobato RD , RivasJJ, SarabiaR, LamasE. Percutaneous microcompression of the gasserian ganglion for trigeminal neuralgia. J. Neurosurg.72(4) , 546–553 (1990).
  • Correa CF , TeixeiraMJ. Balloon compression of the Gasserian ganglion for the treatment of trigeminal neuralgia. Stereotact. Funct. Neurosurg.71(2) , 83–89 (1998).
  • Broggi G , FerroliP, FranziniA, ServelloD, DonesI. Microvascular decompression for trigeminal neuralgia: comments on a series of 250 cases, including 10 patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry68(1) , 59–64 (2000).
  • Pollock BE , EckerRD. A prospective cost–effectiveness study of trigeminal neuralgia surgery. Clin. J. Pain21(4) , 317–322 (2005).
  • Flickinger JC , PollockBE, KondziolkaD et al. Does increased nerve length within the treatment volume improve trigeminal neuralgia radiosurgery? A prospective double-blind, randomized study. Int. J. Radiat. Oncol. Biol. Phys. 51(2) , 449–454 (2001).
  • Kishore-Kumar R , MaxMB, SchaferSC et al. Desipramine relieves postherpetic neuralgia. Clin. Pharmacol. Ther. 47(3) , 305–312 (1990).
  • Watson CP , EvansRJ, ReedK, MerskeyH, GoldsmithL, WarshJ. Amitriptyline versus placebo in postherpetic neuralgia. Neurology32(6) , 671–673 (1982).
  • Graff-Radford SB , ShawLR, NaliboffBN. Amitriptyline and fluphenazine in the treatment of postherpetic neuralgia. Clin. J. Pain16(3) , 188–192 (2000).
  • Goldstein DJ , LuY, DetkeMJ, LeeTC, IvengarS. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain116(1–2) , 109–118 (2005).
  • Raskin J , PritchettYL, WangF et al. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 6(5) , 346–356 (2005).
  • Forssell H , TasmuthT, TenovuoO, HampfG, KalsoE. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial. J. Orofac. Pain18(2) , 131–137 (2004).
  • Moore RA , WiffenPJ, DerryS, McQuayHJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst. Rev.3 , CD007938 (2011).
  • Frampton JE , FosterRH. Pregabalin: in the treatment of postherpetic neuralgia. Drugs65(1) , 111–118 (2005).
  • Norrbrink C , LundebergT. Tramadol in neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled trial. Clin. J. Pain25(3) , 177–184 (2009).
  • Femiano F , GombosF, ScullyC, BusciolanoM, De Luca P. Burning mouth syndrome (BMS): controlled open trial of the efficacy of α-lipoic acid (thioctic acid) on symptomatology. Oral Dis.6(5) , 274–277 (2000).
  • Femiano F . Burning mouth syndrome (BMS): an open trial of comparative efficacy of α-lipoic acid (thioctic acid) with other therapies. Minerva Stomatol.51(9) , 405–409 (2002).
  • Femiano F , ScullyC. Burning mouth syndrome (BMS): double blind controlled study of α lipoic acid (thoictic acid) therapy. J. Oral Pathol. Med.31(5) , 267–269 (2002).
  • Femiano F , GombosF, ScullyC. Burning mouth syndrome: open trial of psychotherapy alone, medication with α-lipoic acid (thioctic acid), and combination therapy. Med. Oral9(1) , 8–13 (2004).
  • Gremeau-Richard C , WodaA, NavezML et al. Topical clonazepam in stomatodynia: a randomized placebo-controlled study. Pain 108(1–2) , 51–57 (2004).
  • Petruzzi M , LauritanoD, De Beneditis M, Baldoni M, Serpico R. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study. J. Oral Pathol. Med.33(2) , 111–114 (2004).
  • Maina G , VitalucciA, GandolfoS, BogettoF. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study. J. Clin. Psychiatry63(1) , 38–43 (2002).
  • White TL , KentPF, KurtzDB, EmkoP. Effectiveness of gabapentin for treatment of burning mouth syndrome. Arch. Otolaryngol. Head Neck Surg.130(6) , 786–788 (2004).
  • Heckmann SM , HeckmannJG, UngethumA, HujoelP, HummelT. Gabapentin has little or no effect in the treatment of burning mouth syndrome – results of an open-label pilot study. Eur. J. Neurol.13(7) , e6–e7 (2006).
  • Lopez V , AlonsoV, MartiN, CalduchL, JordaE. Marked response of burning mouth syndrome to pregabalin treatment. Clin. Exp. Dermatol.34(7) , e449–e450 (2009).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.